Sepracor-Looks very promising Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: BMcV who wrote (1667)	1/23/1999 7:37:00 PM
From: Bob Swift	Read Replies (2) of 10280

Long term attractive..... Does that mean short term unattractive ? May be buying LEAPs instead of buying calls ? Heard that in the latest issue of JAMA someone published a study on a drug call Orlistat which essentially is a lipase inhibitor. Test subjects can eat as much French Fries as they want and still lose weight as the lipids do not get broken down and not absorbed.How is this going to affect the $ 10 billions market for Meridia ? Thinking about it, the side effect of Orlistat (oily stool) and Meridia (constipation) should cancel each other out. Wow! what a winning combination.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next